M
MRVI
Maravai Lifesciences Holdings, I…
2.890
-0.060-2.03%Pre Market: 2.950 +0.060 +2.07%07:13 04/08 EDT
OPEN/PREV CLOSE2.920/2.950
TODAY RANGE2.815-2.941
VOL7.70K
MARKET CAP742.92M
52 WEEK RANGE1.665-4.105
AVG VOL (3M)1.43M
% TURNOVER0.80%
TURNOVER--
P/E (TTM)-3.1902
% RANGE4.27%
EPS(TTM)-0.9059
P/E(FORWARD)-11.1154
P/B3.484
BVPS0.8296
DIVIDEND--
P/S3.983
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP315.36M
SHARES OUTSTANDING257.07M
NEXT EARNINGS05/11-05/15
FREE FLOAT109.12M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
TipRanks·03/01 00:26
Maravai Lifesciences Charts Early Turnaround in 2025
TipRanks·02/27 17:08
Maravai Lifesciences Holdings (MRVI) Receives a Buy from Stifel Nicolaus
Simply Wall St·02/27 01:34
Maravai LifeSciences Holdings (MRVI) Posts US$130.8m TTM Loss Challenging Margin Recovery Narratives
Seeking Alpha·02/26 22:09
Maravai targets $200M–$210M 2026 revenue as restructuring drives early EBITDA turnaround
TipRanks·02/26 15:20
Maravai Lifesciences price target raised to $3 from $2 at Baird
TipRanks·02/26 14:05
Jefferies Remains a Buy on Maravai Lifesciences Holdings (MRVI)
Seeking Alpha·02/25 22:22
Maravai LifeSciences Holdings GAAP EPS of -$0.24 misses by $0.13, revenue of $49.9M beats by $0.84M
TipRanks·02/25 21:17
Maravai Lifesciences reports Q4 adjusted EPS (4c), consensus (7c)
Reuters·02/25 21:17
Maravai LifeSciences Q4 revenue drops less than expected
TipRanks·02/25 21:16
Maravai Lifesciences sees FY26 revenue $200M-$210M, consensus $203.26M
Benzinga·02/25 21:13
Insights into Maravai LifeSciences Q4 Earnings
Same Industry
Name/Symbol
Change%
Price